As SUS become prevalent in the biologics industry, the question of safety becomes increasingly important.
Andreas Nixdorf
Advertisement
Andreas Nixdorf is business development manager Extractables & Leachables Testing at SGS.
Articles by Andreas Nixdorf
Advertisement
Latest Updated Articles
Extractables and Leachables: Determining Risk in Single-Use SystemsPublished: June 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
